These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 15522889)

  • 1. GSK-3beta inhibition/beta-catenin stabilization in ventral midbrain precursors increases differentiation into dopamine neurons.
    Castelo-Branco G; Rawal N; Arenas E
    J Cell Sci; 2004 Nov; 117(Pt 24):5731-7. PubMed ID: 15522889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential regulation of midbrain dopaminergic neuron development by Wnt-1, Wnt-3a, and Wnt-5a.
    Castelo-Branco G; Wagner J; Rodriguez FJ; Kele J; Sousa K; Rawal N; Pasolli HA; Fuchs E; Kitajewski J; Arenas E
    Proc Natl Acad Sci U S A; 2003 Oct; 100(22):12747-52. PubMed ID: 14557550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of antipsychotics on beta-catenin, glycogen synthase kinase-3 and dishevelled in the ventral midbrain of rats.
    Alimohamad H; Sutton L; Mouyal J; Rajakumar N; Rushlow WJ
    J Neurochem; 2005 Oct; 95(2):513-25. PubMed ID: 16144542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BDNF promotes the growth of human neurons through crosstalk with the Wnt/β-catenin signaling pathway via GSK-3β.
    Yang JW; Ru J; Ma W; Gao Y; Liang Z; Liu J; Guo JH; Li LY
    Neuropeptides; 2015 Dec; 54():35-46. PubMed ID: 26311646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Function of Wnts in dopaminergic neuron development.
    Castelo-Branco G; Arenas E
    Neurodegener Dis; 2006; 3(1-2):5-11. PubMed ID: 16909030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of glycogen synthase kinase-3beta attenuates glucocorticoid-induced bone loss.
    Wang FS; Ko JY; Weng LH; Yeh DW; Ke HJ; Wu SL
    Life Sci; 2009 Nov; 85(19-20):685-92. PubMed ID: 19782693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of GSK-3β enhances neural differentiation in unrestricted somatic stem cells.
    Dastjerdi FV; Zeynali B; Tafreshi AP; Shahraz A; Chavoshi MS; Najafabadi IK; Vardanjani MM; Atashi A; Soleimani M
    Cell Biol Int; 2012 Nov; 36(11):967-72. PubMed ID: 22775567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sirtuin 2 enhances dopaminergic differentiation via the AKT/GSK-3β/β-catenin pathway.
    Szegő ÉM; Gerhardt E; Outeiro TF
    Neurobiol Aging; 2017 Aug; 56():7-16. PubMed ID: 28478325
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The beta-chemokines CCL2 and CCL7 are two novel differentiation factors for midbrain dopaminergic precursors and neurons.
    Edman LC; Mira H; Arenas E
    Exp Cell Res; 2008 Jun; 314(10):2123-30. PubMed ID: 18420193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crosstalk between NF-kappaB/p65 and beta-catenin/TCF4/p300 signalling pathways through alterations in GSK-3beta expression during trans-differentiation of endometrial carcinoma cells.
    Saegusa M; Hashimura M; Kuwata T; Hamano M; Okayasu I
    J Pathol; 2007 Sep; 213(1):35-45. PubMed ID: 17607667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alpha-Synuclein Suppresses Retinoic Acid-Induced Neuronal Differentiation by Targeting the Glycogen Synthase Kinase-3β/β-Catenin Signaling Pathway.
    Kim S; Lim J; Bang Y; Moon J; Kwon MS; Hong JT; Jeon J; Seo H; Choi HJ
    Mol Neurobiol; 2018 Feb; 55(2):1607-1619. PubMed ID: 28190238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of glycogen synthase kinase-3beta protects dopaminergic neurons from MPTP toxicity.
    Wang W; Yang Y; Ying C; Li W; Ruan H; Zhu X; You Y; Han Y; Chen R; Wang Y; Li M
    Neuropharmacology; 2007 Jun; 52(8):1678-84. PubMed ID: 17517424
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel indolylmaleimide acts as GSK-3beta inhibitor in human neural progenitor cells.
    Schmöle AC; Brennführer A; Karapetyan G; Jaster R; Pews-Davtyan A; Hübner R; Ortinau S; Beller M; Rolfs A; Frech MJ
    Bioorg Med Chem; 2010 Sep; 18(18):6785-95. PubMed ID: 20708937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The presence of FGF2 signaling determines whether beta-catenin exerts effects on proliferation or neuronal differentiation of neural stem cells.
    Israsena N; Hu M; Fu W; Kan L; Kessler JA
    Dev Biol; 2004 Apr; 268(1):220-31. PubMed ID: 15031118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor beta is required for differentiation of mouse mesencephalic progenitors into dopaminergic neurons in vitro and in vivo: ectopic induction in dorsal mesencephalon.
    Roussa E; Wiehle M; Dünker N; Becker-Katins S; Oehlke O; Krieglstein K
    Stem Cells; 2006 Sep; 24(9):2120-9. PubMed ID: 16741229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ROCK2 regulates bFGF-induced proliferation of SH-SY5Y cells through GSK-3β and β-catenin pathway.
    Boku S; Nakagawa S; Toda H; Kato A; Takamura N; Omiya Y; Inoue T; Koyama T
    Brain Res; 2013 Jan; 1492():7-17. PubMed ID: 23211630
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Axin, a negative regulator of the Wnt signaling pathway, forms a complex with GSK-3beta and beta-catenin and promotes GSK-3beta-dependent phosphorylation of beta-catenin.
    Ikeda S; Kishida S; Yamamoto H; Murai H; Koyama S; Kikuchi A
    EMBO J; 1998 Mar; 17(5):1371-84. PubMed ID: 9482734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrastriatal transforming growth factor alpha delivery to a model of Parkinson's disease induces proliferation and migration of endogenous adult neural progenitor cells without differentiation into dopaminergic neurons.
    Cooper O; Isacson O
    J Neurosci; 2004 Oct; 24(41):8924-31. PubMed ID: 15483111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alterations of beta-catenin and Tcf-4 instead of GSK-3beta contribute to activation of Wnt pathway in hepatocellular carcinoma.
    Cui J; Zhou X; Liu Y; Tang Z; Romeih M
    Chin Med J (Engl); 2003 Dec; 116(12):1885-92. PubMed ID: 14687479
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Generation of dopaminergic neurons in the adult brain from mesencephalic precursor cells labeled with a nestin-GFP transgene.
    Sawamoto K; Nakao N; Kakishita K; Ogawa Y; Toyama Y; Yamamoto A; Yamaguchi M; Mori K; Goldman SA; Itakura T; Okano H
    J Neurosci; 2001 Jun; 21(11):3895-903. PubMed ID: 11356877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.